GIP Antikörper
Kurzübersicht für GIP Antikörper (ABIN355181)
Target
Alle GIP Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- Recognizes human Gastric Inhibitory Polypeptide (GIP). Cross-reactivity: PACAP 10 % and human GLP-2 but <0.1 % with glucagon, GLP-1 or VIP. Binds free GIP in solution.
-
Aufreinigung
- Protein A/G purified
-
Immunogen
-
Synthetic human gastric inhibitory polypeptide coupled to carrier.
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
-
Approved: ELISA (1:10000), IHC, IHC-P
Usage: Suitable for use in ELISA and Immunohistochemistry. ELISA: 1:2000. Using glutaraldehyde-linked GIP-OA (molar ratio 4:1) coated at 1 μg/mL or GIP coated directly at 2 μg/mL. The applications listed have been tested for the unmodified form of this product. Other forms have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.4. No preservative added.
-
Konservierungsmittel
- Azide free
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
-
-
- GIP (Gastric Inhibitory Polypeptide (GIP))
-
Andere Bezeichnung
- GIP
-
Hintergrund
-
Name/Gene ID: GIP
Synonyms: GIP, Incretin hormone, Gastric inhibitory polypeptide -
Gen-ID
- 2695
-
UniProt
- P09681
-
Pathways
- Positive Regulation of Peptide Hormone Secretion, Peptide Hormone Metabolism, Hormone Activity, Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism
Target
-